Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,112.20 -206.04 -1.35%
S&P 500 1,628.93 -22.88 -1.39%
Nasdaq 3,443.20 -38.98 -1.12%
Ticker Volume Price Price Delta
STOXX 50 2,683.98 -16.95 -0.63%
FTSE 100 6,348.82 -25.39 -0.40%
DAX 8,197.08 -32.43 -0.39%
Ticker Volume Price Price Delta
Nikkei 13,069.00 -176.27 -1.33%
Hang Seng 20,487.00 -499.89 -2.38%
S&P/ASX 200 4,756.50 -104.88 -2.16%
  • Exchange: Dublin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Merrion Pharmaceuticals Ltd

+ Add to Watchlist

MERR:ID

0.5950 EUR 0.00000.00%

As of 12:10:02 ET on 06/13/2013.

Snapshot for Merrion Pharmaceuticals Ltd (MERR)

Open: - Day's Range: - Volume: 123,645
Previous Close: 0.5950 52wk Range: 0.2000 - 0.6400 1-Yr Rtn: +197.50%

Stock Chart for MERR

No chart data available.
  • MERR:ID 0.5950
  • 1D
  • 1M
  • 1Y
0.5950
Interactive MERR Chart

Previous Close

Key Statistics for MERR

Current P/E Ratio (ttm) -
Estimated P/E(12/2012) -
Relative P/E vs. ISEQ -
Earnings Per Share (EUR) (ttm) -0.4152
Est. EPS (EUR) (12/2012) -0.0580
Est. PEG Ratio -
Market Cap (M EUR) 10.19
Shares Outstanding (M) 17.13
30 Day Average Volume 7,578
Price/Book (mrq) -
Price/Sale (ttm) 34.4990
Dividend Indicated Gross Yield -%
Cash Dividend -
Last Dividend
5 Year Dividend Growth -
Next Earnings Announcement 09/27/2013
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MERR

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for MERR

Merrion Pharmaceuticals Ltd is a pharmaceutical company. The Company develops drug delivery technologies to improve absorption in the gastrointestinal tract.

More Company Profile & Key Executives for MERR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil